GOP-Led Psilocybin Decriminalization & Research Bill Heads To Oklahoma Senate

A bill to decriminalize low-level possession of psilocybin and promote research into the therapeutic potential of the psychedelic is heading to the Oklahoma Senate after House members gave it the green light.

Sponsored by Rep. Daniel Pae (R), the legislation cleared the chamber in a 62-30 vote, Marijuana Moment reported.

The bill is one of two psilocybin reform measures filed in the Oklahoma House in late January. The other GOP-led proposal filed by Logan Phillips (R) did not contain a decriminalization provision and has yet to receive a committee hearing.

Rep. Pae’s bill seeks to decriminalize possession of up to one-and-a-half ounces of psilocybin by making it punishable by a $400 fine.

The proposal would also explicitly authorize research institutes to obtain psilocybin and utilize it for investigations into treatment efficacy for ten different conditions, such as post-traumatic stress disorder (PTSD), severe depression as well as opioid use disorder.

Under the bill, eligible institutes would need to receive a license for the state Department of Health “for the purposes of growing, studying, processing, and/or dispensing psilocybin-containing fungi or other naturally occurring source organisms, or studying, extracting, synthesizing, and/or dispensing psilocybin or psilocin.”

Veterans' Suicide And Other Mental Health Issues

Chris Moe, an advocate for the bill at the Capitol, told Marijuana Moment that the bill is a chance for Oklahoma to do something about the rising number of veteran suicides and others with difficult to treat mental health issues.

“It’s great to see it pass the state House, as they learn about the ways this can help their constituents,” Moe said. “I look forward to helping educate the state Senate and work towards getting this to the governor’s desk. This is a chance for Oklahoma to help lead the nation in mental health treatment.”

Photo: Courtesy of Anni Roenkae from Pexels

Posted In: billDaniel PaeDecriminalizationMarijuana MomentOklahomaPsilocybinpsychedelicsCannabisGovernmentNewsRegulationsPoliticsTopicsMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.